Cibus, Inc. (NASDAQ:CBUS) Short Interest Up 5.8% in January

Cibus, Inc. (NASDAQ:CBUS) was the target of a large growth in short interest in January. As of January 15th, there was short interest totalling 2,360,000 shares, a growth of 5.8% from the December 31st total of 2,230,000 shares. Based on an average daily volume of 165,400 shares, the days-to-cover ratio is currently 14.3 days. Currently, 12.1% of the shares of the stock are short sold.

Analysts Set New Price Targets

Several research analysts have recently weighed in on the stock. HC Wainwright reissued a “buy” rating and issued a $25.00 target price on shares of Cibus in a research report on Monday, November 11th. Canaccord Genuity Group dropped their price objective on Cibus from $20.00 to $18.00 and set a “buy” rating on the stock in a report on Wednesday, January 22nd.

Cibus Price Performance

Shares of CBUS stock opened at $2.49 on Monday. The firm has a market cap of $65.89 million, a price-to-earnings ratio of -0.11 and a beta of 1.85. The stock’s fifty day simple moving average is $3.20 and its 200 day simple moving average is $4.76. Cibus has a one year low of $2.16 and a one year high of $23.18.

Cibus (NASDAQ:CBUS) last issued its quarterly earnings results on Thursday, November 7th. The company reported $0.06 earnings per share for the quarter, beating analysts’ consensus estimates of ($0.89) by $0.95. Cibus had a negative net margin of 10,724.78% and a negative return on equity of 28.17%. The business had revenue of $1.67 million during the quarter, compared to analyst estimates of $0.47 million. During the same quarter last year, the business posted ($1.59) earnings per share. On average, research analysts anticipate that Cibus will post -2.96 earnings per share for the current year.

Institutional Trading of Cibus

Several hedge funds have recently added to or reduced their stakes in the business. FMR LLC boosted its position in Cibus by 16.9% during the 3rd quarter. FMR LLC now owns 3,913,279 shares of the company’s stock worth $12,757,000 after acquiring an additional 566,328 shares during the last quarter. Wellington Management Group LLP acquired a new stake in shares of Cibus during the 3rd quarter worth about $111,000. Charles Schwab Investment Management Inc. grew its position in shares of Cibus by 14.6% in the third quarter. Charles Schwab Investment Management Inc. now owns 49,285 shares of the company’s stock valued at $161,000 after purchasing an additional 6,276 shares during the last quarter. State Street Corp lifted its holdings in shares of Cibus by 43.6% during the third quarter. State Street Corp now owns 307,262 shares of the company’s stock worth $1,002,000 after buying an additional 93,236 shares in the last quarter. Finally, Barclays PLC grew its position in shares of Cibus by 287.2% during the 3rd quarter. Barclays PLC now owns 20,269 shares of the company’s stock worth $66,000 after purchasing an additional 15,034 shares in the last quarter. Institutional investors and hedge funds own 33.81% of the company’s stock.

Cibus Company Profile

Cibus, Inc, a agricultural biotechnology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases.